Career development
As the field of gene therapies to stimulate cardiac repair is emerging and rapidly evolving, specialist training opportunities remain limited. Through REACT, we address this gap by convening leading experts from the UK and internationally to deliver a …
Subscription complete
Watch your inbox for messages from us soon! Changed you mind about receiving our emails? There is an unsubscribe link at the bottom of all our emails. Our privacy policy explains the basis on which we collect, process and use your personal …
Governance
The MRC/BHF CoRE in Advanced Cardiac Therapies began on 1 January 2025, with a duration of 14 years. Funding has been secured for an initial 7 year period. An experienced leadership team are responsible for delivering CoRE research and impact. Day-to-day …
Leadership team
The REACT leadership team are responsible for all decisions related to the MRC/BHF CoRE in Advanced Cardiac Therapies. The leadership team is chaired by Professor Mauro Giacca , REACT Director, with support from Co-Directors Professor Andy Baker and …